Last updated: July 17, 2026

Application No. 18/684,909

FUCAN AND MODIFIED FUCAN COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO CAPSULAR CONTRACTURE AND TO INHIBITING FIBROUS GROWTH AROUND OR ON TRANSPLANTS

Non-Final OA

Filed

Feb 20, 2024

Priority

Aug 20, 2021 — provisional 63/235,316 +2 more

Examiner

OLSON, ANDREA STEFFEL

Art Unit

Tech Center

Assignee

Arc Medical Inc.

OA Round

1 (Non-Final)

Interview Optional

— -12.2% interview lift. Interview lift (-12.2%) is below the 15.0% threshold. A written response is recommended.

Based on 1415 resolved cases, 2023–2026

Examiner Intelligence

OLSON, ANDREA STEFFEL View full profile →

Grants 62% of resolved cases

Career Allowance Rate

881 granted / 1415 resolved

+2.3% vs TC avg

Minimal -12% lift

Without

With

+-12.2%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

47 currently pending

Career history

1471

Total Applications

across all art units

Statute-Specific Performance

§101

0.4%

-39.6% vs TC avg

§103

55.5%

+15.5% vs TC avg

§102

8.6%

-31.4% vs TC avg

§112

6.0%

-34.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1415 resolved cases

Prosecution Timeline

Feb 20, 2024

Application Filed

Jun 05, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/907,714

Patent 12673070

TREATMENT OF SEPSIS AND HYPERCYTOKINEMIA

3y 9m to grant Granted Jul 07, 2026

17/695,270

Patent 12668790

LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS

4y 3m to grant Granted Jun 30, 2026

18/137,896

Patent 12668577

COMPOUNDS, COMPOSITIONS, AND METHODS FOR ISOLATION OF NUCLEIC ACIDS

3y 2m to grant Granted Jun 30, 2026

18/193,851

Patent 12668669

Method for Preparing Cellulose and Lignin Oil by Depolymerizing Lignocellulose Without Exogenous Hydrogen

3y 3m to grant Granted Jun 30, 2026

17/265,920

Patent 12662494

OPTICALLY ACTIVE BRIDGED PIPERIDINE DERIVATIVE

5y 4m to grant Granted Jun 23, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

50%

With Interview (-12.2%)

3y 1m (~9m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1415 resolved cases by this examiner. Grant probability derived from career allowance rate.